Septic ShockAUSTRALISNCT04693923
Capillary Refill Time Response to a Rapid Fluid Challenge in Septic Shock Patients
A study testing Fluid challenge in people with Septic Shock, run by Pontificia Universidad Catolica de Chile at 1 site in Chile.
Trial summary
In septic shock patients, the hemodynamic coherence between systemic, regional and microcirculatory blood flow can be tracked by "capillary refill time (CRT) response to an increase in stroke volume induced by a rapid fluid challenge". Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Septic Shock
- What is being tested?
- Fluid challenge
- Type of treatment
- Injection or infusion, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 1 siteChile
- Study dates
- 1 Feb 2021to 1 Sep 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Septic shock according to the Sepsis-3 Consensus Conference [1], basically septic patients with hypotension requiring norepinephrine (NE) to maintain a MAP of 65 mmHg, and serum lactate levels > 2 mmol/l after initial fluid resuscitation.
- Less than 24h after fulfilling criteria for septic shock
- Abnormal CRT (>3 secs)
- Mechanical ventilation
- Sinus rhythm with positive predictors of fluid responsiveness [4]
- Continuous CO monitor, arterial line and central venous catheters in place
- Required fluid challenge as decided by the attending physician.
Who cannot join
- Pregnancy
- Emergency surgery or dialytic procedure scheduled within the next two hours
- Do-not-resuscitate status
- Active bleeding
- Severe acute respiratory distress syndrome
- Right ventricular failure
Trial locations and contacts
1 site in 1 country.
Chile1 site
Pontificia Universidad Catolica de Chile
Santiago, Santiago Metropolitan, 7500000
Glenn Hernandez, PhD, +56942106223, glennguru@gmail.com
Ricardo Castro, MPh, +31630717622, rcastro.med@gmail.com
About this study
Official title: Capillary Refill Time Response to a Rapid Fluid Challenge in Septic Shock Patients: Pathophysiological Determinants, and Relation to Changes in Systemic, Regional and Microcirculatory Blood Flow
In septic shock patients, the hemodynamic coherence between systemic, regional and microcirculatory blood flow can be tracked by "capillary refill time (CRT) response to an increase in stroke volume induced by a rapid fluid challenge". A parallel improvement in regional blood flow, microcirculation and hypoperfusion-related parameters should be expected in CRT-responders as reflection of preserved hemodynamic coherence. CRT non-response is associated with a more severe systemic inflammatory state, endothelial and microvascular dysfunction, and a higher adrenergic tone.
The objective of this study is to determine if CRT response after a rapid fluid challenge signals a state of hemodynamic coherence as demonstrated by a parallel improvement in regional and microcirculatory blood flow in CRT-responders, and to explore the pathophysiological mechanisms associated to CRT non-response.
Read the detailed description
INTRODUCTION Septic shock is associated with a high mortality risk of up to 30-60%. Multiple pathogenic factors can lead to progressive tissue hypoperfusion in the context of severe systemic inflammation. However, despite extensive research on the best monitoring and resuscitation strategy many uncertainties persist. Over-resuscitation, particularly when inducing fluid overload, might contribute to a worse outcome. Fluid overload more likely occurs when fluids are administered to fluid unresponsive patients, but also when inappropriate resuscitation goals are pursued. The systematic use of bedside techniques to determine fluid responsiveness (FR) can help to avoid fluid overload. Moreover, further deleterious fluid administration can be prevented by adding the evaluation of hemodynamic coherence in parallel or sequentially to FR. Further research on this topic is imperative considering not only the extremely high morbidity and mortality of septic shock, but also the increasing economic burden over the health system in both developed and low/medium income countries.
CAPILLARY REFILL TIME (CRT) AS A TARGET FOR FLUID RESUSCITATION IN SEPTIC SHOCK The skin territory lacks auto-regulatory flow control, and therefore, sympathetic activation impairs skin perfusion during circulatory dysfunction, a phenomenon that can be evaluated by peripheral perfusion assessment. Abnormal peripheral perfusion after initial or advanced resuscitation is associated with increased morbidity and mortality. A cold clammy skin, mottling or prolonged CRT have been suggested as triggers for fluid resuscitation in patients with septic shock. Moreover, the excellent prognosis associated with CRT recovery, its rapid-response time to fluid loading, its relative simplicity, its availability in resource-limited settings, and its capacity to change in parallel with perfusion of physiologically relevant territories such as the hepatosplanchnic region, constitute strong reasons to consider CRT as a target for fluid resuscitation in septic shock patients.
THE CONCEPT OF A FLUID CHALLENGE Since absolute or relative hypovolemia is almost universally present in early septic shock, resuscitation starts with fluid loading in pre-ICU settings. Fluid loading is the rapid administration of fluids without necessarily monitoring the response in real-time, when confronting severe life-threatening hypotension and hypoperfusion. In this setting, usually 20-30 ml/kg crystalloids are loaded.
If circulatory dysfunction is not resolved with this initial management, patients are transferred to the ICU, where advanced fluid resuscitation is started with the fundamental objective to increase systemic blood flow. The initial step is assessment of FR. Fluid-responsive patients will increase stroke volume >10 to 15% after receiving a fluid bolus (usually 250 to 500 ml of crystalloids) since they are in the ascending part of the Starling curve. On the contrary, being fluid-unresponsive implies to be in the flat part of the curve where fluids will only lead to congestion without increasing stroke volume.
The standard practice is to perform a fluid challenge in fluid-responsive patient who are still hypoperfused. A fluid challenge consists of a fluid bolus, large and rapid enough, to increase venous return and cardiac output (CO) in fluid responsive patients, and eventually improve tissue perfusion, depending on the status of hemodynamic coherence (see below). Fluid is given as a fluid challenge so that response can be assessed looking at the target, and the need for ongoing fluid therapy ascertained.
Very few studies have addressed the best way to perform a fluid challenge. A recent study demonstrated that a minimum of 4 ml/kg fluid bolus maximizes the impact on stroke volume. On the other hand, the rate of administration is also important. The FENICE study found that the most common practice in Europe is to administer 500 ml of crystalloids in 30 minutes as a fluid challenge (standard method). However, a more rapid fluid challenge in 5 to 10 minutes might exert more beneficial effects on tissue perfusion by inducing a vasodilatory reflex in addition to the increase in stroke volume. T
THE CONCEPT AND CLINICAL RELEVANCE OF HEMODYNAMIC COHERENCE IN SEPTIC SHOCK Hemodynamic coherence is the condition in which resuscitation of systemic macrohemodynamic variables results in concurrent improvement in regional and microcirculatory flow, and correction of tissue hypoperfusion. Loss of coherence in septic shock is associated with increasing organ dysfunction and a worse prognosis.
The relationship between macrocirculation and regional/microcirculatory blood flow is conditioned by the predominant pathogenic mechanism at different stages of septic shock. At an early stage, hypovolemia and vascular tone depression predominate, leading to low CO and hypotension. An increase in systemic blood flow induced by fluids and/or vasopressors improves regional and microcirculatory flow at this stage. This suggests that macro- and microcirculation are coupled, and should lead to sustained efforts to increase systemic blood flow until hypoperfusion-related variables are corrected.
At a more advanced stage, excessive adrenergic tone (or high-dose vasopressors), and microvascular/endothelial inflammation predominate, leading to abnormal regional flow distribution, and microcirculatory dysfunction that might not respond to systemic blood flow optimization. Microvascular dysfunction occurs because of endothelial dysfunction, leukocyte-endothelium interactions, coagulation and inflammatory disorders, hemorheologic abnormalities, functional shunting, and as an iatrogenic effect of fluid overload/tissue edema.
Hemodynamic coherence is lost in this advanced stage, and efforts to further increase cardiac CO) with fluids or inodilators might lead to fluid overload and the toxicity of vasoactive agents without improving tissue perfusion.
TRACKING THE STATUS OF HEMODYNAMIC COHERENCE IN SEPTIC SHOCK PATIENTS:
A major risk of ICU-based fluid resuscitation is to induce fluid overload. Administering fluids to patients with septic shock after they lost hemodynamic coherence might deteriorate tissue oxygenation, even if they are still fluid-responsive in cardiac function terms. This is a very important consideration. Assessment of hemodynamic coherence is a step forward over the fluid responsiveness concept. This latter looks at the cardiac function curve, but the former instead at the holistic relationship between different components of the cardiovascular system.
The problem is that no single static parameter can predict the status of hemodynamic coherence, and therefore, fluids are abused and probably contribute to progression to refractory shock and death. This is a fundamental contradiction in septic shock resuscitation and highlights the difference between the concepts of FR and hemodynamic coherence. As an example, patients with capillary leak maintain FR along the process because fluids are rapidly lost to the interstitium, and the severe endothelial/microcirculatory dysfunction precludes reperfusion. So, these patients are both fluid-responsive and uncoupled. Moreover, clinicians in despair keep pushing more fluids to try to correct hypoperfusion, which only worsens microcirculatory abnormalities and further impairs perfusion.
Only a novel dynamic test could reveal if the macrocirculation is still coupled or not to regional/microcirculatory blood flow and prevent mismanagement and fluid overload as stated above. The hypothesis of AUSTRALIS is that CRT response to a single rapid fluid challenge can be used as a novel "hemodynamic coherence test." CRT is a sort of bridge between the two worlds (macro-and microcirculation), since it directly represents systemic blood flow (due to the lack of autoregulation), and microcirculation. Normalization of CRT represents an improvement in regional and microcirculatory skin perfusion secondary to an increase in systemic blood flow and/or a reactive decrease in adrenergic tone, thus reflecting hemodynamic coherence. On the contrary, CRT non-response after a rapid fluid challenge is abnormal and a signal of loss of coherence.
PATHOPHYSIOLOGICAL DETERMINANTS OF CRT NON-RESPONSE There are many possible explanations on why CRT might not respond to a stroke volume increase induced by a fluid challenge. Some of these possible mechanisms will be addressed in the proposed study. Adrenergic tone and systemic inflammation, and endothelial/coagulation dysfunction will be addressed by a series of biomarkers selected to provide a broad overview of systemic inflammatory/anti-inflammatory response, and of the transition between endothelial/coagulation activation to established dysfunction, plus direct visualization of microcirculatory status under the tongue, and assessment of microvascular reactivity.
CLINICAL RELEVANCE OF THE PRESENT STUDY If the hypothesis is confirmed, CRT-response to a rapid fluid challenge could be used as a hemodynamic coherence test, and help to avoid futile and dangerous further fluid administration in uncoupled patients, and eventually reduce additional iatrogenic-related excess mortality. Fluid resuscitation could then be focused in fluid responsive patients in whom hemodynamic coherence is still preserved while other perfusion parameters are still not normalized.
Furthermore, establishing the status of hemodynamic coherence with this simple test in pre-ICU or resource-limited settings, could eventually aid in taking triage decisions. CRT non-responders who concentrate septic shock mortality might be rapidly transferred to hospitals with ICU facilities for advanced monitoring and treatment, including reinforcement of source control and eventually rescue therapies.
At the end, this study will help to position CRT, a costless, universally available, and simple test, not only as key target for septic shock resuscitation, but also as a dynamic test of the circulatory function that might help clinicians to interpret the stage of evolution, and help to take timely and critical decisions on fluid resuscitation beyond the concept of fluid responsiveness.
For research purposes, CRT response is defined by "CRT-normalization", and not by "CRT improvement but without normalization" which will be categorized as CRT non-response. This is because hemodynamic tests require to be dichotomous to be applied on a decision branch. In addition, normalization is the only alternative to get certainty that reperfusion has been completed. In any case, partial response will be also included in post-hoc analyses, and the results of the test are not of a binding nature for attending intensivists.
OBJECTIVES AND HYPOTHESIS OR RESEARCH QUESTIONS HYPOTHESIS: In septic shock patients, the hemodynamic coherence between systemic, regional and microcirculatory blood flow can be tracked by "CRT response to an increase in stroke volume induced by a rapid fluid challenge". A parallel improvement in regional blood flow, microcirculation and hypoperfusion-related parameters should be expected in CRT-responders as reflection of preserved hemodynamic coherence. CRT non-response is associated with a more severe systemic inflammatory state, endothelial and microvascular dysfunction, and a higher adrenergic tone.
GENERAL OBJECTIVE: To determine if CRT response after a rapid fluid challenge signals a state of hemodynamic coherence as demonstrated by a parallel improvement in regional and microcirculatory blood flow in CRT-responders, and to explore the pathophysiological mechanisms associated to CRT non-response.
SPECIFIC OBJECTIVES
- To determine if CRT normalization after an increase in stroke volume (>10%) induced by a rapid fluid challenge is associated with a parallel improvement in regional, microcirculatory blood flow and perfusion variables.
- To determine if the rate of fluid challenge (rapid vs. standard) influences CRT response rate.
- To determine if CRT non-response is associated with a more severe systemic inflammatory state, endothelial and microvascular dysfunction, and a higher adrenergic tone.
- Conditions
- Septic Shock
- Being tested
- Fluid challenge
- Medical subject headings
- Shock, Septic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Fluid challengeProcedure or surgery
Fluid challenge according to the assigned group
| Study group | Role | What they receive |
|---|---|---|
| Group A (rapid fluid challenge) | Experimental | Patients will receive a rapid fluid challenge (4ml/kg of crystalloids in 5 minutes using a syringe of 60 mL and a timer in the multiparameter monitor). Receives: Procedure: Fluid challenge |
| Group B (standard fluid challenge) | Active comparator | Patients will receive a standard fluid challenge (500 ml of crystalloids in 30 minutes). Receives: Procedure: Fluid challenge |
What is being measured
The primary outcome is the main question the study is designed to answer.
Normalization of capillary refill time (CRT)
CRT-response is defined as normalization of the variable after the fluid challenge (normal value CRT ≤3.0 secs).
Measured: At baseline, and immediately after the single fluid challenge; then at 30 minutes, and 1, 2, 6 and 24h.
Secondary outcomes (11)
Procalcitonin
Inflammation biomarker assessed in serum samples (upper normal limits according to assay)
Measured: Baseline, and at 6 and 24h after the single fluid challenge
IL-6
Inflammation biomarker assessed in serum samples (upper normal limits according to assay)
Measured: Baseline, and at 6 and 24h after the single fluid challenge
IL-10
Inflammation biomarker assessed in serum samples (upper normal limits according to assay)
Measured: Baseline, and at 6 and 24h after the single fluid challenge
TNF-alpha
Inflammation biomarker assessed in serum samples (upper normal limits according to assay)
Measured: Baseline, and at 6 and 24h after the single fluid challenge
Syndecan-1
Marker of endothelial dysfunction, assessed in serum samples (upper normal limits according to assay)
Measured: Baseline, and at 6 and 24h after the single fluid challenge
s- ICAM-1
Marker of endothelial dysfunction, assessed in serum samples (upper normal limits according to assay)
Measured: Baseline, and at 6 and 24h after the single fluid challenge
E-selectin
Marker of endothelial dysfunction, assessed in serum samples (upper normal limits according to assay)
Measured: Baseline, and at 6 and 24h after the single fluid challenge
von Willebrand factor
Marker of endothelial dysfunction, assessed in serum samples (upper normal limits according to assay)
Measured: Baseline, and at 6 and 24h after the single fluid challenge
Platelet count
Marker of coagulation abnormalities, assessed in serum samples (normal >150.000)
Measured: Baseline, and at 6 and 24h after the single fluid challenge
P-selectin
Marker of coagulation abnormalities, assessed in serum samples (upper normal limits according to assay)
Measured: Baseline, and at 6 and 24h after the single fluid challenge
D-Dimer
Marker of coagulation abnormalities, assessed in serum samples (upper normal limits according to assay)
Measured: Baseline, and at 6 and 24h after the single fluid challenge
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jan 2021
- Study start1 Feb 2021 (estimated)
- Primary completion1 Jun 2023 (estimated)
- Study completion1 Sep 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (70)Papers the sponsor has linked to this study.
- Other trials for Septic ShockStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This is a randomized controlled study in parallel groups.
- Masking
- None (open label)
- Enrolment
- 42 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Pontificia Universidad Catolica de Chile
- Sponsor type
- University, hospital or other
- Collaborators
- Fondo Nacional de Desarrollo Científico y Tecnológico, Chile
- Responsible party
- Principal investigator, Glenn Hernández, Pontificia Universidad Catolica de Chile
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04693923
- Sponsor's protocol ID
- 190527001
- Acronym
- AUSTRALIS
- Status last verified
- Dec 2020
- First submitted
- 21 Dec 2020
- Last updated
- 5 Jan 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Will be available on a website 6 months after completing recruitment
Publications
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
PubMed 26903338Hernandez G, Bruhn A, Castro R, Regueira T. The holistic view on perfusion monitoring in septic shock. Curr Opin Crit Care. 2012 Jun;18(3):280-6. doi: 10.1097/MCC.0b013e3283532c08.
PubMed 22473257Malbrain ML, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ, Van Regenmortel N. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 2014 Nov-Dec;46(5):361-80. doi: 10.5603/AIT.2014.0060.
PubMed 25432556Jozwiak M, Monnet X, Teboul JL. Prediction of fluid responsiveness in ventilated patients. Ann Transl Med. 2018 Sep;6(18):352. doi: 10.21037/atm.2018.05.03.
PubMed 30370279Ince C. Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care. 2015;19 Suppl 3(Suppl 3):S8. doi: 10.1186/cc14726. Epub 2015 Dec 18.
PubMed 26729241Machado FR, Cavalcanti AB, Bozza FA, Ferreira EM, Angotti Carrara FS, Sousa JL, Caixeta N, Salomao R, Angus DC, Pontes Azevedo LC; SPREAD Investigators; Latin American Sepsis Institute Network. The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study. Lancet Infect Dis. 2017 Nov;17(11):1180-1189. doi: 10.1016/S1473-3099(17)30322-5. Epub 2017 Aug 17.
PubMed 28826588Hernandez G, Castro R, Romero C, de la Hoz C, Angulo D, Aranguiz I, Larrondo J, Bujes A, Bruhn A. Persistent sepsis-induced hypotension without hyperlactatemia: is it really septic shock? J Crit Care. 2011 Aug;26(4):435.e9-14. doi: 10.1016/j.jcrc.2010.09.007. Epub 2010 Dec 3.
PubMed 21126850Hernandez G, Luengo C, Bruhn A, Kattan E, Friedman G, Ospina-Tascon GA, Fuentealba A, Castro R, Regueira T, Romero C, Ince C, Bakker J. When to stop septic shock resuscitation: clues from a dynamic perfusion monitoring. Ann Intensive Care. 2014 Oct 11;4:30. doi: 10.1186/s13613-014-0030-z. eCollection 2014.
PubMed 25593746Ospina-Tascon GA, Umana M, Bermudez W, Bautista-Rincon DF, Hernandez G, Bruhn A, Granados M, Salazar B, Arango-Davila C, De Backer D. Combination of arterial lactate levels and venous-arterial CO2 to arterial-venous O 2 content difference ratio as markers of resuscitation in patients with septic shock. Intensive Care Med. 2015 May;41(5):796-805. doi: 10.1007/s00134-015-3720-6. Epub 2015 Mar 20.
PubMed 25792204Tapia P, Soto D, Bruhn A, Alegria L, Jarufe N, Luengo C, Kattan E, Regueira T, Meissner A, Menchaca R, Vives MI, Echeverria N, Ospina-Tascon G, Bakker J, Hernandez G. Impairment of exogenous lactate clearance in experimental hyperdynamic septic shock is not related to total liver hypoperfusion. Crit Care. 2015 Apr 22;19(1):188. doi: 10.1186/s13054-015-0928-3.
PubMed 25898244Hernandez G, Regueira T, Bruhn A, Castro R, Rovegno M, Fuentealba A, Veas E, Berrutti D, Florez J, Kattan E, Martin C, Ince C. Relationship of systemic, hepatosplanchnic, and microcirculatory perfusion parameters with 6-hour lactate clearance in hyperdynamic septic shock patients: an acute, clinical-physiological, pilot study. Ann Intensive Care. 2012 Oct 15;2(1):44. doi: 10.1186/2110-5820-2-44.
PubMed 23067578Hernandez G, Boerma EC, Dubin A, Bruhn A, Koopmans M, Edul VK, Ruiz C, Castro R, Pozo MO, Pedreros C, Veas E, Fuentealba A, Kattan E, Rovegno M, Ince C. Severe abnormalities in microvascular perfused vessel density are associated to organ dysfunctions and mortality and can be predicted by hyperlactatemia and norepinephrine requirements in septic shock patients. J Crit Care. 2013 Aug;28(4):538.e9-14. doi: 10.1016/j.jcrc.2012.11.022. Epub 2013 Apr 6.
PubMed 23566729Hernandez G, Ospina-Tascon GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, Friedman G, Castro R, Alegria L, Teboul JL, Cecconi M, Ferri G, Jibaja M, Pairumani R, Fernandez P, Barahona D, Granda-Luna V, Cavalcanti AB, Bakker J; The ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN); Hernandez G, Ospina-Tascon G, Petri Damiani L, Estenssoro E, Dubin A, Hurtado J, Friedman G, Castro R, Alegria L, Teboul JL, Cecconi M, Cecconi M, Ferri G, Jibaja M, Pairumani R, Fernandez P, Barahona D, Cavalcanti AB, Bakker J, Hernandez G, Alegria L, Ferri G, Rodriguez N, Holger P, Soto N, Pozo M, Bakker J, Cook D, Vincent JL, Rhodes A, Kavanagh BP, Dellinger P, Rietdijk W, Carpio D, Pavez N, Henriquez E, Bravo S, Valenzuela ED, Vera M, Dreyse J, Oviedo V, Cid MA, Larroulet M, Petruska E, Sarabia C, Gallardo D, Sanchez JE, Gonzalez H, Arancibia JM, Munoz A, Ramirez G, Aravena F, Aquevedo A, Zambrano F, Bozinovic M, Valle F, Ramirez M, Rossel V, Munoz P, Ceballos C, Esveile C, Carmona C, Candia E, Mendoza D, Sanchez A, Ponce D, Ponce D, Lastra J, Nahuelpan B, Fasce F, Luengo C, Medel N, Cortes C, Campassi L, Rubatto P, Horna N, Furche M, Pendino JC, Bettini L, Lovesio C, Gonzalez MC, Rodruguez J, Canales H, Caminos F, Galletti C, Minoldo E, Aramburu MJ, Olmos D, Nin N, Tenzi J, Quiroga C, Lacuesta P, Gaudin A, Pais R, Silvestre A, Olivera G, Rieppi G, Berrutti D, Ochoa M, Cobos P, Vintimilla F, Ramirez V, Tobar M, Garcia F, Picoita F, Remache N, Granda V, Paredes F, Barzallo E, Garces P, Guerrero F, Salazar S, Torres G, Tana C, Calahorrano J, Solis F, Torres P, Herrera L, Ornes A, Perez V, Delgado G, Lopez A, Espinosa E, Moreira J, Salcedo B, Villacres I, Suing J, Lopez M, Gomez L, Toctaquiza G, Cadena Zapata M, Orazabal MA, Pardo Espejo R, Jimenez J, Calderon A, Paredes G, Barberan JL, Moya T, Atehortua H, Sabogal R, Ortiz G, Lara A, Sanchez F, Hernan Portilla A, Davila H, Mora JA, Calderon LE, Alvarez I, Escobar E, Bejarano A, Bustamante LA, Aldana JL. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA. 2019 Feb 19;321(7):654-664. doi: 10.1001/jama.2019.0071.
PubMed 30772908Hernandez G, Tapia P, Alegria L, Soto D, Luengo C, Gomez J, Jarufe N, Achurra P, Rebolledo R, Bruhn A, Castro R, Kattan E, Ospina-Tascon G, Bakker J. Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock. Crit Care. 2016 Aug 2;20(1):234. doi: 10.1186/s13054-016-1419-x.
PubMed 27480413Hernandez G, Bruhn A, Castro R, Pedreros C, Rovegno M, Kattan E, Veas E, Fuentealba A, Regueira T, Ruiz C, Ince C. Persistent Sepsis-Induced Hypotension without Hyperlactatemia: A Distinct Clinical and Physiological Profile within the Spectrum of Septic Shock. Crit Care Res Pract. 2012;2012:536852. doi: 10.1155/2012/536852. Epub 2012 Apr 18.
PubMed 22570774
Study at a glance
From the registry record, last updated by the sponsor on 5 Jan 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Capillary Refill Time Response to a Rapid Fluid Challenge in Septic Shock Patients: Pathophysiological Determinants, and Relation to Changes in Systemic, Regional and Microcirculatory Blood Flow
- ClinicalTrials.gov ID
- NCT04693923
- Acronym / sponsor ID
- AUSTRALIS / 190527001
- Conditions
- Septic Shock
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 42 participants (estimated)
- Lead sponsor
- Pontificia Universidad Catolica de ChileUniversity, hospital or other
- Collaborators
- Fondo Nacional de Desarrollo Científico y Tecnológico, Chile
- Study start
- 1 Feb 2021 (estimated)
- Primary completion
- 1 Jun 2023 (estimated)
- Study completion
- 1 Sep 2023 (estimated)
- First posted
- 5 Jan 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In septic shock patients, the hemodynamic coherence between systemic, regional and microcirculatory blood flow can be tracked by "capillary refill time (CRT) response to an increase in stroke volume induced by a rapid fluid challenge". A parallel improvement in regional blood flow, microcirculation and hypoperfusion-related parameters should be expected in CRT-responders as reflection of preserved hemodynamic coherence. CRT non-response is associated with a more severe systemic inflammatory state, endothelial and microvascular dysfunction, and a higher adrenergic tone.
The objective of this study is to determine if CRT response after a rapid fluid challenge signals a state of hemodynamic coherence as demonstrated by a parallel improvement in regional and microcirculatory blood flow in CRT-responders, and to explore the pathophysiological mechanisms associated to CRT non-response.
Detailed description
INTRODUCTION Septic shock is associated with a high mortality risk of up to 30-60%. Multiple pathogenic factors can lead to progressive tissue hypoperfusion in the context of severe systemic inflammation. However, despite extensive research on the best monitoring and resuscitation strategy many uncertainties persist. Over-resuscitation, particularly when inducing fluid overload, might contribute to a worse outcome. Fluid overload more likely occurs when fluids are administered to fluid unresponsive patients, but also when inappropriate resuscitation goals are pursued. The systematic use of bedside techniques to determine fluid responsiveness (FR) can help to avoid fluid overload. Moreover, further deleterious fluid administration can be prevented by adding the evaluation of hemodynamic coherence in parallel or sequentially to FR. Further research on this topic is imperative considering not only the extremely high morbidity and mortality of septic shock, but also the increasing economic burden over the health system in both developed and low/medium income countries.
CAPILLARY REFILL TIME (CRT) AS A TARGET FOR FLUID RESUSCITATION IN SEPTIC SHOCK The skin territory lacks auto-regulatory flow control, and therefore, sympathetic activation impairs skin perfusion during circulatory dysfunction, a phenomenon that can be evaluated by peripheral perfusion assessment. Abnormal peripheral perfusion after initial or advanced resuscitation is associated with increased morbidity and mortality. A cold clammy skin, mottling or prolonged CRT have been suggested as triggers for fluid resuscitation in patients with septic shock. Moreover, the excellent prognosis associated with CRT recovery, its rapid-response time to fluid loading, its relative simplicity, its availability in resource-limited settings, and its capacity to change in parallel with perfusion of physiologically relevant territories such as the hepatosplanchnic region, constitute strong reasons to consider CRT as a target for fluid resuscitation in septic shock patients.
THE CONCEPT OF A FLUID CHALLENGE Since absolute or relative hypovolemia is almost universally present in early septic shock, resuscitation starts with fluid loading in pre-ICU settings. Fluid loading is the rapid administration of fluids without necessarily monitoring the response in real-time, when confronting severe life-threatening hypotension and hypoperfusion. In this setting, usually 20-30 ml/kg crystalloids are loaded.
If circulatory dysfunction is not resolved with this initial management, patients are transferred to the ICU, where advanced fluid resuscitation is started with the fundamental objective to increase systemic blood flow. The initial step is assessment of FR. Fluid-responsive patients will increase stroke volume >10 to 15% after receiving a fluid bolus (usually 250 to 500 ml of crystalloids) since they are in the ascending part of the Starling curve. On the contrary, being fluid-unresponsive implies to be in the flat part of the curve where fluids will only lead to congestion without increasing stroke volume.
The standard practice is to perform a fluid challenge in fluid-responsive patient who are still hypoperfused. A fluid challenge consists of a fluid bolus, large and rapid enough, to increase venous return and cardiac output (CO) in fluid responsive patients, and eventually improve tissue perfusion, depending on the status of hemodynamic coherence (see below). Fluid is given as a fluid challenge so that response can be assessed looking at the target, and the need for ongoing fluid therapy ascertained.
Very few studies have addressed the best way to perform a fluid challenge. A recent study demonstrated that a minimum of 4 ml/kg fluid bolus maximizes the impact on stroke volume. On the other hand, the rate of administration is also important. The FENICE study found that the most common practice in Europe is to administer 500 ml of crystalloids in 30 minutes as a fluid challenge (standard method). However, a more rapid fluid challenge in 5 to 10 minutes might exert more beneficial effects on tissue perfusion by inducing a vasodilatory reflex in addition to the increase in stroke volume. T
THE CONCEPT AND CLINICAL RELEVANCE OF HEMODYNAMIC COHERENCE IN SEPTIC SHOCK Hemodynamic coherence is the condition in which resuscitation of systemic macrohemodynamic variables results in concurrent improvement in regional and microcirculatory flow, and correction of tissue hypoperfusion. Loss of coherence in septic shock is associated with increasing organ dysfunction and a worse prognosis.
The relationship between macrocirculation and regional/microcirculatory blood flow is conditioned by the predominant pathogenic mechanism at different stages of septic shock. At an early stage, hypovolemia and vascular tone depression predominate, leading to low CO and hypotension. An increase in systemic blood flow induced by fluids and/or vasopressors improves regional and microcirculatory flow at this stage. This suggests that macro- and microcirculation are coupled, and should lead to sustained efforts to increase systemic blood flow until hypoperfusion-related variables are corrected.
At a more advanced stage, excessive adrenergic tone (or high-dose vasopressors), and microvascular/endothelial inflammation predominate, leading to abnormal regional flow distribution, and microcirculatory dysfunction that might not respond to systemic blood flow optimization. Microvascular dysfunction occurs because of endothelial dysfunction, leukocyte-endothelium interactions, coagulation and inflammatory disorders, hemorheologic abnormalities, functional shunting, and as an iatrogenic effect of fluid overload/tissue edema.
Hemodynamic coherence is lost in this advanced stage, and efforts to further increase cardiac CO) with fluids or inodilators might lead to fluid overload and the toxicity of vasoactive agents without improving tissue perfusion.
TRACKING THE STATUS OF HEMODYNAMIC COHERENCE IN SEPTIC SHOCK PATIENTS:
A major risk of ICU-based fluid resuscitation is to induce fluid overload. Administering fluids to patients with septic shock after they lost hemodynamic coherence might deteriorate tissue oxygenation, even if they are still fluid-responsive in cardiac function terms. This is a very important consideration. Assessment of hemodynamic coherence is a step forward over the fluid responsiveness concept. This latter looks at the cardiac function curve, but the former instead at the holistic relationship between different components of the cardiovascular system.
The problem is that no single static parameter can predict the status of hemodynamic coherence, and therefore, fluids are abused and probably contribute to progression to refractory shock and death. This is a fundamental contradiction in septic shock resuscitation and highlights the difference between the concepts of FR and hemodynamic coherence. As an example, patients with capillary leak maintain FR along the process because fluids are rapidly lost to the interstitium, and the severe endothelial/microcirculatory dysfunction precludes reperfusion. So, these patients are both fluid-responsive and uncoupled. Moreover, clinicians in despair keep pushing more fluids to try to correct hypoperfusion, which only worsens microcirculatory abnormalities and further impairs perfusion.
Only a novel dynamic test could reveal if the macrocirculation is still coupled or not to regional/microcirculatory blood flow and prevent mismanagement and fluid overload as stated above. The hypothesis of AUSTRALIS is that CRT response to a single rapid fluid challenge can be used as a novel "hemodynamic coherence test." CRT is a sort of bridge between the two worlds (macro-and microcirculation), since it directly represents systemic blood flow (due to the lack of autoregulation), and microcirculation. Normalization of CRT represents an improvement in regional and microcirculatory skin perfusion secondary to an increase in systemic blood flow and/or a reactive decrease in adrenergic tone, thus reflecting hemodynamic coherence. On the contrary, CRT non-response after a rapid fluid challenge is abnormal and a signal of loss of coherence.
PATHOPHYSIOLOGICAL DETERMINANTS OF CRT NON-RESPONSE There are many possible explanations on why CRT might not respond to a stroke volume increase induced by a fluid challenge. Some of these possible mechanisms will be addressed in the proposed study. Adrenergic tone and systemic inflammation, and endothelial/coagulation dysfunction will be addressed by a series of biomarkers selected to provide a broad overview of systemic inflammatory/anti-inflammatory response, and of the transition between endothelial/coagulation activation to established dysfunction, plus direct visualization of microcirculatory status under the tongue, and assessment of microvascular reactivity.
CLINICAL RELEVANCE OF THE PRESENT STUDY If the hypothesis is confirmed, CRT-response to a rapid fluid challenge could be used as a hemodynamic coherence test, and help to avoid futile and dangerous further fluid administration in uncoupled patients, and eventually reduce additional iatrogenic-related excess mortality. Fluid resuscitation could then be focused in fluid responsive patients in whom hemodynamic coherence is still preserved while other perfusion parameters are still not normalized.
Furthermore, establishing the status of hemodynamic coherence with this simple test in pre-ICU or resource-limited settings, could eventually aid in taking triage decisions. CRT non-responders who concentrate septic shock mortality might be rapidly transferred to hospitals with ICU facilities for advanced monitoring and treatment, including reinforcement of source control and eventually rescue therapies.
At the end, this study will help to position CRT, a costless, universally available, and simple test, not only as key target for septic shock resuscitation, but also as a dynamic test of the circulatory function that might help clinicians to interpret the stage of evolution, and help to take timely and critical decisions on fluid resuscitation beyond the concept of fluid responsiveness.
For research purposes, CRT response is defined by "CRT-normalization", and not by "CRT improvement but without normalization" which will be categorized as CRT non-response. This is because hemodynamic tests require to be dichotomous to be applied on a decision branch. In addition, normalization is the only alternative to get certainty that reperfusion has been completed. In any case, partial response will be also included in post-hoc analyses, and the results of the test are not of a binding nature for attending intensivists.
OBJECTIVES AND HYPOTHESIS OR RESEARCH QUESTIONS HYPOTHESIS: In septic shock patients, the hemodynamic coherence between systemic, regional and microcirculatory blood flow can be tracked by "CRT response to an increase in stroke volume induced by a rapid fluid challenge". A parallel improvement in regional blood flow, microcirculation and hypoperfusion-related parameters should be expected in CRT-responders as reflection of preserved hemodynamic coherence. CRT non-response is associated with a more severe systemic inflammatory state, endothelial and microvascular dysfunction, and a higher adrenergic tone.
GENERAL OBJECTIVE: To determine if CRT response after a rapid fluid challenge signals a state of hemodynamic coherence as demonstrated by a parallel improvement in regional and microcirculatory blood flow in CRT-responders, and to explore the pathophysiological mechanisms associated to CRT non-response.
SPECIFIC OBJECTIVES
- To determine if CRT normalization after an increase in stroke volume (>10%) induced by a rapid fluid challenge is associated with a parallel improvement in regional, microcirculatory blood flow and perfusion variables.
- To determine if the rate of fluid challenge (rapid vs. standard) influences CRT response rate.
- To determine if CRT non-response is associated with a more severe systemic inflammatory state, endothelial and microvascular dysfunction, and a higher adrenergic tone.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- This is a randomized controlled study in parallel groups.
| Arm | Type | Receives |
|---|---|---|
| Group A (rapid fluid challenge) | Experimental | Procedure: Fluid challengePatients will receive a rapid fluid challenge (4ml/kg of crystalloids in 5 minutes using a syringe of 60 mL and a timer in the multiparameter monitor). |
| Group B (standard fluid challenge) | Active comparator | Procedure: Fluid challengePatients will receive a standard fluid challenge (500 ml of crystalloids in 30 minutes). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Septic shock according to the Sepsis-3 Consensus Conference [1], basically septic patients with hypotension requiring norepinephrine (NE) to maintain a MAP of 65 mmHg, and serum lactate levels > 2 mmol/l after initial fluid resuscitation.
- Less than 24h after fulfilling criteria for septic shock
- Abnormal CRT (>3 secs)
- Mechanical ventilation
- Sinus rhythm with positive predictors of fluid responsiveness [4]
Key exclusion criteria (6 listed)
- Pregnancy
- Emergency surgery or dialytic procedure scheduled within the next two hours
- Do-not-resuscitate status
- Active bleeding
- Severe acute respiratory distress syndrome
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Fluid challengeFluid challenge according to the assigned group | Procedure or surgery | Group A (rapid fluid challenge), Group B (standard fluid challenge) |
Primary outcome
Normalization of capillary refill time (CRT)
Time frame: At baseline, and immediately after the single fluid challenge; then at 30 minutes, and 1, 2, 6 and 24h.
CRT-response is defined as normalization of the variable after the fluid challenge (normal value CRT ≤3.0 secs).
11 secondary outcomes
Procalcitonin
Time frame: Baseline, and at 6 and 24h after the single fluid challenge
IL-6
Time frame: Baseline, and at 6 and 24h after the single fluid challenge
IL-10
Time frame: Baseline, and at 6 and 24h after the single fluid challenge
TNF-alpha
Time frame: Baseline, and at 6 and 24h after the single fluid challenge
Syndecan-1
Time frame: Baseline, and at 6 and 24h after the single fluid challenge
s- ICAM-1
Time frame: Baseline, and at 6 and 24h after the single fluid challenge
E-selectin
Time frame: Baseline, and at 6 and 24h after the single fluid challenge
von Willebrand factor
Time frame: Baseline, and at 6 and 24h after the single fluid challenge
Platelet count
Time frame: Baseline, and at 6 and 24h after the single fluid challenge
P-selectin
Time frame: Baseline, and at 6 and 24h after the single fluid challenge
D-Dimer
Time frame: Baseline, and at 6 and 24h after the single fluid challenge
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jan 2021.
- Background: PubMed 26903338Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
- Background: PubMed 22473257Hernandez G, Bruhn A, Castro R, Regueira T. The holistic view on perfusion monitoring in septic shock. Curr Opin Crit Care. 2012 Jun;18(3):280-6. doi: 10.1097/MCC.0b013e3283532c08.
- Background: PubMed 25432556Malbrain ML, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ, Van Regenmortel N. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 2014 Nov-Dec;46(5):361-80. doi: 10.5603/AIT.2014.0060.
- Background: PubMed 30370279Jozwiak M, Monnet X, Teboul JL. Prediction of fluid responsiveness in ventilated patients. Ann Transl Med. 2018 Sep;6(18):352. doi: 10.21037/atm.2018.05.03.
- Background: PubMed 26729241Ince C. Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care. 2015;19 Suppl 3(Suppl 3):S8. doi: 10.1186/cc14726. Epub 2015 Dec 18.
- Background: PubMed 28826588Machado FR, Cavalcanti AB, Bozza FA, Ferreira EM, Angotti Carrara FS, Sousa JL, Caixeta N, Salomao R, Angus DC, Pontes Azevedo LC; SPREAD Investigators; Latin American Sepsis Institute Network. The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study. Lancet Infect Dis. 2017 Nov;17(11):1180-1189. doi: 10.1016/S1473-3099(17)30322-5. Epub 2017 Aug 17.
- Background: PubMed 21126850Hernandez G, Castro R, Romero C, de la Hoz C, Angulo D, Aranguiz I, Larrondo J, Bujes A, Bruhn A. Persistent sepsis-induced hypotension without hyperlactatemia: is it really septic shock? J Crit Care. 2011 Aug;26(4):435.e9-14. doi: 10.1016/j.jcrc.2010.09.007. Epub 2010 Dec 3.
- Background: PubMed 25593746Hernandez G, Luengo C, Bruhn A, Kattan E, Friedman G, Ospina-Tascon GA, Fuentealba A, Castro R, Regueira T, Romero C, Ince C, Bakker J. When to stop septic shock resuscitation: clues from a dynamic perfusion monitoring. Ann Intensive Care. 2014 Oct 11;4:30. doi: 10.1186/s13613-014-0030-z. eCollection 2014.
- Background: PubMed 25792204Ospina-Tascon GA, Umana M, Bermudez W, Bautista-Rincon DF, Hernandez G, Bruhn A, Granados M, Salazar B, Arango-Davila C, De Backer D. Combination of arterial lactate levels and venous-arterial CO2 to arterial-venous O 2 content difference ratio as markers of resuscitation in patients with septic shock. Intensive Care Med. 2015 May;41(5):796-805. doi: 10.1007/s00134-015-3720-6. Epub 2015 Mar 20.
- Background: PubMed 25898244Tapia P, Soto D, Bruhn A, Alegria L, Jarufe N, Luengo C, Kattan E, Regueira T, Meissner A, Menchaca R, Vives MI, Echeverria N, Ospina-Tascon G, Bakker J, Hernandez G. Impairment of exogenous lactate clearance in experimental hyperdynamic septic shock is not related to total liver hypoperfusion. Crit Care. 2015 Apr 22;19(1):188. doi: 10.1186/s13054-015-0928-3.
- Background: PubMed 23067578Hernandez G, Regueira T, Bruhn A, Castro R, Rovegno M, Fuentealba A, Veas E, Berrutti D, Florez J, Kattan E, Martin C, Ince C. Relationship of systemic, hepatosplanchnic, and microcirculatory perfusion parameters with 6-hour lactate clearance in hyperdynamic septic shock patients: an acute, clinical-physiological, pilot study. Ann Intensive Care. 2012 Oct 15;2(1):44. doi: 10.1186/2110-5820-2-44.
- Background: PubMed 23566729Hernandez G, Boerma EC, Dubin A, Bruhn A, Koopmans M, Edul VK, Ruiz C, Castro R, Pozo MO, Pedreros C, Veas E, Fuentealba A, Kattan E, Rovegno M, Ince C. Severe abnormalities in microvascular perfused vessel density are associated to organ dysfunctions and mortality and can be predicted by hyperlactatemia and norepinephrine requirements in septic shock patients. J Crit Care. 2013 Aug;28(4):538.e9-14. doi: 10.1016/j.jcrc.2012.11.022. Epub 2013 Apr 6.
- Individual participant dataSharing planned: Yes. Will be available on a website 6 months after completing recruitment
Related trials for Septic Shock
Not yet recruitingObservational study
Serum GDF-15 and LGALS3BP as Prognostic Biomarkers in Sepsis
Sepsis, Septic Shock
RecruitingPhase 3
A Trial of Adjunctive Fludrocortisone (50mcg, 100mcg or Placebo) in Critically Ill Patients With Septic Shock Receiving Hydrocortisone, Evaluating Survival and Functional Recovery and the Influence of Transcriptomic Response
Septic Shock
Recruiting
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
Sepsis - to Reduce Mortality in the Intensive Care Unit, Septic Shock
Not yet recruiting
Hemodynamic Resuscitation Guided by Non-Invasive Mean Systemic Filling Pressure to Prevent Acute Kidney Injury in Septic Shock
Acute Kidney Injury Due to Sepsis
RecruitingObservational study
Clinical Value of EMR3 in Sepsis Diagnosis, Monitoring, and Prognosis: A Multicenter Prospective Observational Study
Sepsis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Fluid challenge in people with Septic Shock, run by Pontificia Universidad Catolica de Chile at 1 site in Chile.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 5 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Normalization of capillary refill time (CRT) (time frame: At baseline, and immediately after the single fluid challenge; then at 30 minutes, and 1, 2, 6 and 24h.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04693923, which also lists 70 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2021.